T cell Reactivity to Collagen Ii as a Possible Prognostic Marker in Patients with Rheumatoid Arthritis. | [Journal of Pakistan Medical Association • 2018]

Author(s):

1. Nida Saleem: Armed Forces Institute of Pathology (AFIP), National University of Medical Sciences (NUMS), Rawalpindi, Pakistan

2. Tahir Aziz Ahmed: Armed Forces Institute of Pathology (AFIP), National University of Medical Sciences (NUMS), Rawalpindi, Pakistan

3. Mukarram Bashir: Armed Forces Institute of Pathology (AFIP), National University of Medical Sciences (NUMS), Rawalpindi, Pakistan

4. Muhammad Omair Riaz: Armed Forces Institute of Pathology (AFIP), National University of Medical Sciences (NUMS), Rawalpindi, Pakistan

5. Ali Hamid: Military Hospital (MH), Rawalpindi, Pakistan

Abstract:

Objective: To compare the frequency and the functional state of the collagen II reactive T cells with disease activity in rheumatoid arthritis patients and healthy controls. Methods: This case-control cross-sectional study was carried out at the Department of Immunology; Armed Forces Institute of Pathology, Rawalpindi, Pakistan, from June to October 2014. Rheumatologist from Rehmat Noor Rheumatology Clinic, a private health facility of the city, was requested to send in patients with clinical diagnosis of rheumatoid arthritis. Samples were obtained and relevant investigations were carried out. Data were compared with a group of age and gender-matched healthy subjects. T cell proliferative response was assessed against bovine collagen II by measuring incorporation of bromodeoxyuridine into deoxyribonucleic acid of proliferating cells and by expression of CD25 on proliferating cells as percentage of CD3+/bromodeoxyuridine+ and CD3+/CD25+ T-cells, respectively. Among the patients, the frequency of T cells with disease activity was compared. Patients were classified into groups of mild, moderate and severe disease and frequency of CD3+/bromodeoxyuridine+, frequency of CD3+/CD25+ cells, mean fluorescent intensity of bromodeoxyuridine-fluorescein isothiocyanate and mean fluorescent intensity of CD25-fluorescein isothiocyanate were compared in the groups. Results: Of the 60 subjects, 30(50%)were patients and 30(50%) were controls. Of the patients, 5(16.66%) were males and 25(83.33%) were females with an overall mean age of 42±12 years. The mean age of the controls was 41±9.28 years. Mean disease duration of the patients was 10.5 ± 4.2 years. Percentage of CD3+/CD25+ cells and CD3+/bromodeoxyuridine+ cells stimulated with collagen II, in patients was much higher than the controls(p<0.05).Statistically significant differences were observed when frequency of CD3+/bromodeoxyuridine+ cells and CD3+/CD25+ cells was compared among the mild, moderate and severe patient groups (p<0.05). Conclusion: Collagen II was found to be an important auto antigen in joints of rheumatoid arthritis patients.

Page(s): 1222-1227

DOI: DOI not available

Published: Journal: Journal of Pakistan Medical Association, Volume: 68, Issue: 8, Year: 2018

Keywords:

Keywords are not available for this article.

References:

[1] RemmersEF,PlengeRM,LeeAT,GrahamRR,HomG,BehrensTW, 2007.STAT4 and the Risk of Rheumatoid Arthritis and Systemic Lupus Erythematosus,N Engl J Med 357 977 -86

[2] OhnishiY,TsutsumiA,MatsumotoI,GotoD,ItoS,KuwanaM, 2006.Altered peptide ligands control type II collagen-reactive T cells from rheumatoid arthritis patients,Mod Rheumatol 16 226 -8

[3] CopeAP, 2008.T cells in rheumatoid arthritis,Arthritis Res Ther 10 S1 -

[4] LathamKA,WhittingtonKB,ZhouR,QianZ,RosloniecEF, 2005.Ex Vivo Characterisation of the Autoimmune T Cell Response in the HLADR1 Mouse Model of Collagen-Induced Arthritis Reveals LongTerm Activation of Type II Collagen-Specific Cells and Their Presence in Arthritic Joints,J Immunol 174 3978 -85

[5] ChoiJJ,YooSA,ParkSJ,KangYJ, 2008.Mesenchymal stem cells overexpressing interleukin-10 attenuate collagen-induced arthritis in mice,Clin ExpImmunol 153 269 -76

[6] ZhuP,LiXY,WangHK,JiaJF,ZhengZH,DingJ, 2007.Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collageninduced arthritis,Clin Immunol 122 75 -84

[7] DupontWD,PlummerWD, 1998.Power and Sample Size Calculations for Studies Involving Linear Regression,Control Clin Trials 19 589 -601

[8] .ACR-endorsed Criteria for Rheumatic Diseases,[Cited 2017 Sept 14 -

[9] AletahaD,SmolenJ, 2005.The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis,Clin Exp Rheumatol 23 S100 -8

[10] MinSY,YanM,DuY,WuT,KhobahyE,KwonSR, 2013.Intraarticular nuclear factor-?B blockade ameliorates collagen-induced arthritis in mice by eliciting regulatory T cells and macrophages,Clin ExpImmunol 172 217 -27

[11] TeratoK,HarperDS,GriffithsMM,HastyDL,YeXJ,CremerMA, .Collagen-induced arthritis in mice: synergistic effect of E. coli lipopolysaccharide bypasses epitope specificity in the induction of arthritis with monoclonal antibodies to type II collagen, -

[12] 1995.,Autoimmunity 22 137 -47

[13] HeX,KangAH,StuartJM, 2000.Accumulation of T cells reactive to type II collagen in synovial fluid of patients with rheumatoid arthritis,J Rheumatol 27 589 -93

[14] NissimA,WinyardPG,CorrigallV,FatahR,PerrettD,PanayiG, 2005.Generation of neoantigenic epitopes after posttranslational modification of type II collagen by factors present within the inflamed joint,Arthritis Rheum 52 3829 -38

[15] TrenthamDE,DynesiusRA,RocklinRE,DavidJR, 1978.Cellular sensitivity to collagen in rheumatoid arthritis,Trans Assoc Am Physicians 91 118 -28

[16] TrenthamDE,Dynesius-TrenthamRA,OravEJ,CombitchiD,LorenzoC,SewellKL, 1993.Effects of oral administration of type II collagen on rheumatoid arthritis,Science 261 1727 -30

[17] TrenthamDE,TownesAS,KangAH, 1977.Autoimmunity to type II collagen an experimental model of arthritis,J Exp Med 146 857 -68

[18] StuartJM,PostlethwaiteAE,TownesAS,KangAH, 1980.Cell-mediated immunity to collagen and collagen alpha chains in rheumatoid arthritis and other rheumatic diseases,Am J Med 69 13 -8

[19] LondeiM,SavillCM,VerhoefA,BrennanF,LeechZA,DuanceV, 1989.Persistence of collagen type II-specific T-cell clones in the synovial membrane of a patient with rheumatoid arthritis,Proc Natl Acad Sci USA 86 636 -40

[20] DesaiBV,DixitS,PopeRM, 1989.Limited proliferative response to type II collagen in rheumatoid arthritis,J Rheumatol 16 1310 -4

[21] SnowdenN,ReynoldsI,MorganK, 1997.T cell responses to human type II collagen in patients with rheumatoid arthritis and healthy controls,Arthritis Rheum 40 1210 -8

[22] HolmdahlR,AnderssonME,GoldschmidtTJ,JanssonL,KarlssonM,MalmströmV, 1989.Collagen induced arthritis as an experimental model for rheumatoid arthritis. Immunogenetics, pathogenesis and autoimmunity,APMIS 97 575 -84

[23] MainoVC,SuniMA,RuitenbergJJ, 1995.Rapid flow cytometric method for measuring lymphocyte subset activation,Cytometry 20 127 -33

[24] KubbiesM,SchindlerD,HoehnH,RabinovitchPS, 1985.BrdU-Hoechst flow cytometry reveals regulation of human lymphocyte growth by donor-age-related growth fraction and transition rate,J Cell Physiol 125 229 -34

[25] ZhuP,LiXY,WangHK,JiaJF,ZhengZH,DingJ, 2007.Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collageninduced arthritis,Clin Immunol 122 75 -84

[26] Von BaehrV,MayerW,LiebenthalC,von BaehrR,BiegerW,VolkHD, 2001.Improving the in vitro antigen specific T cell proliferation assay: the use of interferon-alpha to elicit antigen specific stimulation and decrease bystander proliferation,J Immunol Methods 251 63 -71

[27] ZhuP,LiX,DingJ,FanC,WangY,WangH, .Simultaneous detection of DNA synthesis, activation and cytokine secretion in collagen II (250-270)-activated T lymphocytes by flow cytometry, -

[28] 2004.,Cell Biol Int 28 765 -72

[29] Van der GraaffWL,PrinsAP,DijkmansBA,van LierRA., 1931.Prognostic value of Th1/Th2 ratio in rheumatoid arthritis,Lancet 351 -

[30] 2002.Cytokine modulation and suppression of liver injury by a novel analogue of thalidomide,Eur J Pharmacol 453 325 -34

[31] 1997.,Cytometry 27 71 -6

[32] NguyenXD,EichlerH,DugrillonA,PiechaczekC,BraunM,Klüter H, 2003.Flow cytometric analysis of T cell proliferation in a mixed lymphocyte reaction with dendritic cells,J Immunol Methods 275 57 -68

[33] ChilsonOP,Kelly-ChilsonAE, 1989.Mitogeniclectins bind to the antigen receptor on human lymphocytes,Eur J Immunol 19 389 -96

[34] DankeNA,KoelleDM,YeeC,BeherayS,KwokWW, 2004.Autoreactive T cells in healthy individuals,J Immunol 172 5967 -70

Citations

Downloads

Views